Abstract:Background Fistulae represent a frequent complication in Crohn's disease (CD).Surgical resection is often required, as medical treatment outcome with conventional drugs is often insufficient.We have previously demonstrated that epithelial-to-mesenchymal transition (EMT) plays a critical role for fistula development.The T cell cytokines tumor necrosis factor (TNF), interleukin (IL)-13, interferon (IFN) g, IL-17A and IL-22 are highly expressed in transitional cells along fistula tracts in CD patients.Similar to transforming growth factor (TGF) b, TNF is able to induce EMT and the expression of molecules being associated with cell invasiveness and migration.IL-13 has no impact on epithelial cell morphology, but also induces expression of genes being associated with invasive cell growth, such as SLUG transcription factor and b6-integrin.Here, we analyzed the implication of the T cell-derived cytokines IFNg, IL-17A and IL-22 in the event of EMT.Moreover, we investigated if there are differences in the composition of lymphocytes in the blood of CD patients suffering from fistulae compared to patients without fistulae or healthy controls.Methods Threedimensional intestinal epithelial cell (IEC) constructs (spheroids) were stimulated with IFN g, IL-17A and IL-22 to investigate the effects on EMT development.Further, CD4+ and CD25+ T cells were isolated from fistulizing CD patients' blood or control blood samples and cocultured together with HT29 cells.Afterwards, mRNA expression levels of EMT-associated genes were analyzed.Results Treatment of the in vitro spheroid model with IFNg resulted in a loss of the well-defined globular spheroid shape after day 7.We observed a clear separation of IECs, while mRNA levels for EMT-related transcription factors like SNAIL-1 and ETS-1 were not up-regulated.IL-17A and IL-22 had no effect on cell morphology suggesting that they do not induce EMT in our cell model.On a molecular level, both cytokines had no effect on the mRNA expression of EMT-associated genes, but prevented the TGFb-induced up-regulation of e.g.SNAIL-1 or ETS-1.The sorting of T cells isolated from blood of CD patients with fistulae revealed an elevated expression level of CD4+ and CD25+ T cells compared to healthy controls.Conclusions Our data demonstrate that T cell derived cytokines may play a crucial role in the pathogenesis of CD-associated fistulae.Th1 cell-derived IFNg may be involved in the event of EMT in IECs, however Th17 cellderived cytokines IL-17A and IL-22 are likely not implicated in EMT onset, and may prevent EMT-associated effects of TGFb.This observation supports the hypothesis that Th17 cellderived cytokines exert a pivotal role for maintaining intestinal homeostasis.The different lymphocyte composition in CD patients' blood represents a further hint for the importance of these cells in fistulae formation.

Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency

Fut2 deficiency aggravates chronic colitis through 2-oxindole-AHR mediated cGAS-STING pathway

Exogenous L ‐fucose Protects the Intestinal Mucosal Barrier Depending on Upregulation of FUT2‐mediated Fucosylation of Intestinal Epithelial Cells

Intestinal Epithelium-Specific Fut2 Deficiency Promotes Colorectal Cancer Through Down-Regulating Fucosylation of MCAM.

2′-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression

Sa1852 Computational Prediction and Validation of UPF1 As a Novel Molecule for Ulcerative Colitis

Fucose Ameliorate Intestinal Inflammation Through Modulating the Crosstalk Between Bile Acids and Gut Microbiota in a Chronic Colitis Murine Model.

Altered Gut Microbiome in FUT2 Loss-of-function Mutants in Support of Personalized Medicine for Inflammatory Bowel Diseases.

Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation

FGL2 improves experimental colitis related to gut microbiota structure and bile acid metabolism by regulating macrophage autophagy and apoptosis

2'-Fucosyllactose Restores the Intestinal Mucosal Barrier in Ulcerative Colitis by Inhibiting STAT3 Palmitoylation and Phosphorylation

Protection against DSS-induced colitis in mice through FcεRIα deficiency: the role of altered Lactobacillus

Faecal Microbiota Transplantation Reduces Susceptibility to Epithelial Injury and Modulates Tryptophan Metabolism of the Microbial Community in a Piglet Model

FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response

Alleviative effects of exopolysaccharides from Limosilactobacillus mucosae CCFM1273 against ulcerative colitis via modulation of gut microbiota and inhibition of Fas/Fasl and TLR4/NF-κB pathways

Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway

Gut microbiota-mediated alleviation of dextran sulfate sodium-induced colitis in mice.

Human TFF2-Fc Fusion Protein Alleviates DSS-induced Ulcerative Colitis in C57BL/6 Mice by Promoting Intestinal Epithelial Cells Repair and Inhibiting Macrophage Inflammation

Lower fecal microbiota transplantation ameliorates ulcerative colitis by eliminating oral-derived Fusobacterium nucleatum and virulence factor

2'-Fucosyllactose Promotes Colonization of Akkermansia muciniphila and Prevents Colitis In Vitro and in Mice